NDC Package 72730-111-01 Truseltiq

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72730-111-01
Package Description:
1 BLISTER PACK in 1 CARTON / 21 CAPSULE in 1 BLISTER PACK
Product Code:
Proprietary Name:
Truseltiq
Usage Information:
TRUSELTIQ is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test [see Dosage and Administration ( 2.1)] . This indication is approved under accelerated approval based on overall response rate and duration of response [see Clinical Studies ( 14.1)] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
11-Digit NDC Billing Format:
72730011101
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2551004 - infigratinib 100 MG Oral Capsule
  • RxCUI: 2551005 - {21 (infigratinib 100 MG Oral Capsule) } Pack
  • RxCUI: 2551005 - infigratinib 100 MG Daily Dose, 100 MG Oral Capsule 21 Count Pack
  • RxCUI: 2551005 - infigratinib 100 MG Daily Dose Carton, 1 Blister Card, 21 Capsules Each
  • RxCUI: 2551011 - TRUSELTIQ 100 MG Oral Capsule
  • Labeler Name:
    Qed Therapeutics, Inc.
    Sample Package:
    No
    Start Marketing Date:
    05-28-2021
    Listing Expiration Date:
    12-31-2023
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72730-111-01?

    The NDC Packaged Code 72730-111-01 is assigned to a package of 1 blister pack in 1 carton / 21 capsule in 1 blister pack of Truseltiq, labeled by Qed Therapeutics, Inc.. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 72730-111 included in the NDC Directory?

    No, Truseltiq with product code 72730-111 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Qed Therapeutics, Inc. on May 28, 2021 and its listing in the NDC Directory is set to expire on December 31, 2023 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 72730-111-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 72730-111-01?

    The 11-digit format is 72730011101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272730-111-015-4-272730-0111-01